How multiplexed imaging reveals key insights into the tumor microenvironment to inform treatment and improve outcomes

Multiplexed immunofluorescent imaging sheds new light on cancer and other complex conditions. This imaging technique offers a deeper understanding of cells and their surroundings by providing a detailed view of disease biology, including different cell types, biomarker expression, and immune response. The ability to both quantify and spatially analyze cellular biomarkers in tissue, coupled with the opportunity to decipher cellular mechanisms for innovative targeted treatment strategies, has the potential to make cancer therapeutics more targeted and effective than before.

 

In this webinar, we will discuss how collaborative efforts and a focus on the critical needs of patients, researchers, and industry led to the development of Cell DIVE™ multiplexed immunofluorescence imaging. We incorporated existing, proven technologies and customer feedback to validate and continuously improve this novel imaging solution, providing new knowledge to all involved and advancing immuno-oncology in the process.

 

Learning Objectives: